QIAGEN

ISIN NL0015002CX3

 | 

WKN A40ZZU

Marktkapitalisatie (in EUR)
8,613 m
Land
Netherlands
Sector
Healthcare
Dividendrendement
0.54%
 

Overzicht

Beschrijving

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. The firm assay technologies make these biomolecules visible and ready for analysis. Its bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996, and is headquartered in Venlo, the Netherlands.
Toon meer Toon minder
Healthcare Healthcare Equipment Diagnostics and Drug Delivery Devices Netherlands

Financiële kerngegevens

Kerncijfers

Marktkapitalisatie, EUR 8,613 m
WPA, EUR 1.68
KBV 2.8
K/W 25.1
Dividendrendement 0.54%

Winst- en verliesrekening (2024)

Omzet, EUR 1,829 m
Netto-inkomen, EUR 77 m
Winstmarge 4.23%
Nieuwste artikelen
Populaire artikelen
— Gegevens verstrekt door Trackinsight, etfinfo, Xignite Inc., gettex, FactSet en justETF GmbH.

Standaard zijn ETF-rendementen inclusief dividenduitkeringen (indien van toepassing). Er is geen garantie voor de volledigheid, juistheid en correctheid van de getoonde informatie.